Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Varta, Rock Tech Lithium, Millennial Lithium - all signs point to growth

ON THE AUTHOR: Carsten Mainitz The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research. Most r...
Carsten Mainitz | March 23, 2021 |

NASDAQ Listing & $100M Sales Guidance Fuels Peak’s H2/21

eResearch is pleased to publish an update Equity Research Report on Peak Fintech Group (PKK) ( CSE.PKK , OTC: PKKFF , Forum ) pertaining to the recent release of its revenue & EBITDA guidance. We are maintaining our Speculative Buy rating and increasing our one-year pr...
Featured Submission | August 3, 2021 |

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |

Colombia is open for resource investing

Following a recent group email exchange with Louis James, the truly tireless editor of Casey’s International Speculator currently kicking rocks in Colombia, one of the non-Casey Research participants in the exchange commented, “You guys are doing it right. ...
Dr. Allen Alper of Metals News | October 28, 2012 |

FOMC Minutes Reveal an Important Shift That’s Key for Gold, Too

Yesterday, the Fed released minutes from its last meeting . They show an important shift among the meeting participants. In September, the FOMC turned more worried about the state of the U.S. economy, while just six weeks later in October, the Committee felt more optimist...
Arkadiusz Sieron | November 22, 2019 |

Big Picture Outlook: Seat Belts Tightened

"Gold is money; everything else is credit." —J.P. Morgan Dating back to the mid-80s, and usually around the end of November, I begin to formulate strategies and portfolios looking out to the upcoming New Year, taking into account technical, fundamental and geopolitica...
Streetwise Reports | December 3, 2019 |

Contact Gold Goes Back to the Bowl Zone to Hit Higher-Grade Gold

Going back to the Bowl Zone yields the desired results After a successful exploration campaign in 2018, wherein Contact Gold Corp. (C:TSX.V) confirmed the widespread presence of gold mineralization on its greater Pony Creek area (with very thick intervals such as 93...
Streetwise Reports | July 22, 2019 |

Moderna Shares Rise on the Release of Positive Results from Two mRNA Phase 1 Programs

Shares of Moderna Inc. traded up double-digits today as the firm announced results from its Phase 1 CMV Vaccine Study as well as its Phase 1 data for mRNA-1944 encoding for antibody against the chikungunya virus. This morning clinical-stage biotechnology company Mode...
Streetwise Reports | September 13, 2019 |

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

Goodbye Goldcorp, Hello Newmont

Goodbye Goldcorp, Hello Newmont Source: Adrian Day for Streetwise Reports 04/22/2019 Fund manager Adrian Day reviews the Goldcorp-Newmont merger as well as provides updates on a number of resource companies in his portfolio, including some that he sees as good buys....
Streetwise Reports | April 23, 2019 |
1 2 3 4 5 6 7 8 9 10 ...